Lymphoma

Table of Contents

  1. What is Lymphoma?
  2. Types of Lymphoma
  3. Causes and Risk Factors
  4. Symptoms of Lymphoma
  5. Diagnosis and Treatment
  6. Prognosis
  7. Research Papers
  8. Connections
  9. Featured Videos

What is Lymphoma?

Lymphoma is a type of cancer that begins in the lymphatic system, which is part of the body's immune system. It affects lymphocytes, a type of white blood cell that helps the body fight infections.

Types of Lymphoma

1. Hodgkin Lymphoma (HL)

2. Non-Hodgkin Lymphoma (NHL)

Causes and Risk Factors

The exact cause of lymphoma is not fully understood, but certain risk factors have been identified:

Symptoms of Lymphoma

Common signs and symptoms include:

Diagnosis and Treatment

Diagnosis

Diagnosing lymphoma involves a variety of tests and procedures:

Treatment Options

Treatment depends on the type and stage of lymphoma and may include:

Prognosis

The prognosis for lymphoma varies based on factors such as the type (Hodgkin or non-Hodgkin), stage at diagnosis, and the patient’s overall health. Advances in treatment have significantly improved survival rates for many forms of lymphoma.


References & Research

Historical Background

Hodgkin lymphoma was first described by English physician Thomas Hodgkin in 1832, who identified the distinctive pattern of lymph node enlargement in autopsy specimens. The identification of Reed-Sternberg cells by Dorothy Reed and Carl Sternberg around 1900 provided the histological hallmark of Hodgkin disease. Non-Hodgkin lymphomas were later classified as a separate group, with Henry Rappaport’s classification system in 1966 being an early milestone.

Key Research Papers

  1. Younes A, Gopal AK, Smith SE, et al. Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin’s lymphoma. J Clin Oncol. 2012;30(18):2183-2189.
  2. Schmitz R, Wright GW, Huang DW, et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 2018;378(15):1396-1407.
  3. Neelapu SS, Locke FL, Bartlett NL, et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma (ZUMA-1). N Engl J Med. 2017;377(26):2531-2544.
  4. Shanbhag S, Ambinder RF. Hodgkin lymphoma: a review and update on recent progress. CA Cancer J Clin. 2018;68(2):116-132.
  5. Ansell SM, Lesokhin AM, Borrello I, et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma. N Engl J Med. 2015;372(4):311-319.
  6. Coiffier B, Thieblemont C, Van Den Neste E, et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing R-CHOP to standard CHOP in DLBCL. Blood. 2010;116(12):2040-2045.
  7. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-2390.
  8. Younes A, Santoro A, Shipp M, et al. Nivolumab for classical Hodgkin’s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin (CheckMate 205). J Clin Oncol. 2016;34(31):3733-3739.
  9. A predictive model for aggressive non-Hodgkin’s lymphoma. International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329(14):987-994.
  10. Sehn LH, Gascoyne RD. Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. Blood. 2015;125(1):22-32.
  11. Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-Hodgkin lymphoma. The Lancet. 2017;390(10091):298-310.
  12. Abramson JS, Palomba ML, Gordon LI, et al. Lisocabtagene maraleucel for relapsed or refractory large B-cell lymphoma (TRANSCEND NHL 001). The Lancet. 2020;396(10254):839-852.

Back to Table of Contents


Research Papers

The following PubMed topic searches surface the current peer-reviewed literature on Lymphoma. Each link opens a live PubMed query; results update as new papers are indexed.

  1. PubMed search: lymphoma
  2. PubMed search: Hodgkin lymphoma
  3. PubMed search: non Hodgkin lymphoma
  4. PubMed search: diffuse large B cell lymphoma
  5. PubMed search: follicular lymphoma
  6. PubMed search: mantle cell lymphoma
  7. PubMed search: lymphoma rituximab
  8. PubMed search: lymphoma CAR T cell therapy
  9. PubMed search: lymphoma PET CT staging
  10. PubMed search: lymphoma Ann Arbor staging
  11. PubMed search: lymphoma checkpoint inhibitor
  12. PubMed search: cutaneous T cell lymphoma

Back to Table of Contents


Connections

Back to Table of Contents


Video Thumbnail

Mayo Clinic Explains Lymphoma

Video Thumbnail

Non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology

Video Thumbnail

Doctor explains how Hodgkin Lymphoma spreads, plus risk factors & treatment options | Stanford

Video Thumbnail

Non-Hodgkin Lymphoma: First Symptoms, Diagnosis & the LATEST Treatments | The Patient Story

Video Thumbnail

Lymphoma: Signs, Symptoms, Treatment | Max Hospital

Video Thumbnail

Lymphoma Diagnosis

Video Thumbnail

Hodgkin's lymphoma: What you need to know - Mayo Clinic

Video Thumbnail

Follicular Lymphoma: Everything You Need to Know

Video Thumbnail

What is low-grade non-Hodgkin lymphoma?